S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
The Safest Option in Trades! (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
The Safest Option in Trades! (Ad)pixel
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
A One Stop Shop for Everything Futures Trading (Ad)pixel
Tesla sales bounce back in Q3 but fall short of estimates
UK's Truss sticks by economic plan as her party worries
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
The Safest Option in Trades! (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
The Safest Option in Trades! (Ad)pixel
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
A One Stop Shop for Everything Futures Trading (Ad)pixel
Tesla sales bounce back in Q3 but fall short of estimates
UK's Truss sticks by economic plan as her party worries
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
The Safest Option in Trades! (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
The Safest Option in Trades! (Ad)pixel
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
A One Stop Shop for Everything Futures Trading (Ad)pixel
Tesla sales bounce back in Q3 but fall short of estimates
UK's Truss sticks by economic plan as her party worries
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
The Safest Option in Trades! (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
The Safest Option in Trades! (Ad)pixel
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
A One Stop Shop for Everything Futures Trading (Ad)pixel
Tesla sales bounce back in Q3 but fall short of estimates
UK's Truss sticks by economic plan as her party worries
NYSE:NUS

Nu Skin Enterprises - NUS Stock Forecast, Price & News

$33.37
-0.49 (-1.45%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$33.29
$34.02
50-Day Range
$33.37
$47.20
52-Week Range
$33.29
$56.76
Volume
533,938 shs
Average Volume
370,877 shs
Market Capitalization
$1.68 billion
P/E Ratio
15.03
Dividend Yield
4.55%
Price Target
$58.50

Nu Skin Enterprises MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
61.8% Upside
$54.00 Price Target
Short Interest
Bearish
5.27% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.56
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$1.26 M Sold Last Quarter
Proj. Earnings Growth
8.58%
From $3.38 to $3.67 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.32 out of 5 stars

Consumer Staples Sector

61st out of 144 stocks

Drugs, Proprietaries, & Sundries Industry

5th out of 7 stocks

NUS stock logo

About Nu Skin Enterprises (NYSE:NUS) Stock

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Receive NUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.

NUS Stock News Headlines

NU Skin Enterprises is Oversold
Nu Skin Enterprises Inc.
Nu Skin (NUS) Down More Than 15% in 3 Months: Here's Why
Nu Skin Enterprises (NUS) Q2 Earnings Lag Estimates
See More Headlines
Receive NUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.

NUS Company Calendar

Last Earnings
8/04/2022
Ex-Dividend for 9/7 Dividend
8/25/2022
Dividend Payable
9/07/2022
Today
10/02/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Personal Products
CUSIP
67018T10
Employees
4,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$54.00
High Stock Price Forecast
$75.00
Low Stock Price Forecast
$40.00
Forecasted Upside/Downside
+75.3%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
2 Analysts

Profitability

Net Income
$147.27 million
Pretax Margin
7.26%

Debt

Sales & Book Value

Annual Sales
$2.70 billion
Cash Flow
$5.70 per share
Book Value
$18.29 per share

Miscellaneous

Free Float
48,802,000
Market Cap
$1.68 billion
Optionable
Optionable
Beta
1.16

Key Executives

  • Mr. Steven J. Lund (Age 69)
    Exec. Chairman
    Comp: $827.03k
  • Mr. Ryan S. Napierski (Age 48)
    Pres, CEO & Director
    Comp: $1.46M
  • Mr. Mark H. Lawrence (Age 52)
    Exec. VP & CFO
    Comp: $918.58k
  • Dr. Joseph Y. Chang Ph.D. (Age 69)
    Exec. VP & Chief Scientific Officer
    Comp: $1.13M
  • Mr. Chayce David Clark (Age 39)
    Exec. VP & Gen. Counsel
    Comp: $540.92k
  • Mr. Ritch N. WoodMr. Ritch N. Wood (Age 56)
    Exec. Advisor
    Comp: $1.53M
  • Mr. D. Matthew DornyMr. D. Matthew Dorny (Age 58)
    Legal Advisor
    Comp: $687.56k
  • Ms. Mang Yee Tang (Age 51)
    Exec. VP and Chief Global Growth & Customer Experience Officer
    Comp: $796.45k
  • Mr. Blake M. Roney (Age 63)
    Founder
  • Ms. Sandra N. Tillotson (Age 65)
    Founder













NUS Stock - Frequently Asked Questions

Should I buy or sell Nu Skin Enterprises stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NUS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View NUS analyst ratings
or view top-rated stocks.

What is Nu Skin Enterprises' stock price forecast for 2022?

2 Wall Street research analysts have issued 1 year price objectives for Nu Skin Enterprises' stock. Their NUS share price forecasts range from $40.00 to $75.00. On average, they predict the company's share price to reach $54.00 in the next year. This suggests a possible upside of 61.8% from the stock's current price.
View analysts price targets for NUS
or view top-rated stocks among Wall Street analysts.

How have NUS shares performed in 2022?

Nu Skin Enterprises' stock was trading at $50.75 at the beginning of 2022. Since then, NUS stock has decreased by 34.2% and is now trading at $33.37.
View the best growth stocks for 2022 here
.

When is Nu Skin Enterprises' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our NUS earnings forecast
.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) announced its quarterly earnings results on Thursday, August, 4th. The company reported $0.77 EPS for the quarter, missing the consensus estimate of $0.79 by $0.02. The company had revenue of $560.62 million for the quarter, compared to the consensus estimate of $559.91 million. Nu Skin Enterprises had a trailing twelve-month return on equity of 19.78% and a net margin of 4.57%.

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Thursday, August 4th. Stockholders of record on Friday, August 26th will be given a dividend of $0.385 per share on Wednesday, September 7th. This represents a $1.54 dividend on an annualized basis and a yield of 4.61%. The ex-dividend date of this dividend is Thursday, August 25th.
Read our dividend analysis for NUS
.

Is Nu Skin Enterprises a good dividend stock?

Nu Skin Enterprises (NYSE:NUS) pays an annual dividend of $1.54 per share and currently has a dividend yield of 4.55%. NUS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 21 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 69.37%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, NUS will have a dividend payout ratio of 41.96% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NUS.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises issued an update on its third quarter 2022 earnings guidance on Thursday, September, 1st. The company provided EPS guidance of $0.70-$0.85 for the period, compared to the consensus earnings per share estimate of $0.89. The company issued revenue guidance of $550.00 million-$590.00 million, compared to the consensus revenue estimate of $630.91 million.

What is Ritch Wood's approval rating as Nu Skin Enterprises' CEO?

72 employees have rated Nu Skin Enterprises Chief Executive Officer Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among the company's employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

How do I buy shares of Nu Skin Enterprises?

Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $33.37.

How much money does Nu Skin Enterprises make?

Nu Skin Enterprises (NYSE:NUS) has a market capitalization of $1.68 billion and generates $2.70 billion in revenue each year. The company earns $147.27 million in net income (profit) each year or $2.22 on an earnings per share basis.

How many employees does Nu Skin Enterprises have?

The company employs 4,600 workers across the globe.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The official website for the company is www.nuskinenterprises.com. The company can be reached via phone at (801) 345-1000, via email at investorrelations@nuskin.com, or via fax at 801-345-5999.

This page (NYSE:NUS) was last updated on 10/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.